share_log
Breakings ·  Nov 21 19:10
Zymeworks Shares up 2.5% Premarket After FDA Approves Co, Jazz Pharma's Biliary Tract Cancer Drug
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment